A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.

Autor: Matusiak N; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands., Castelli R; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Tuin AW; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Overkleeft HS; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Wisastra R; Department of Pharmaceutical Gene Modulation, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Dekker FJ; Department of Pharmaceutical Gene Modulation, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Prély LM; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Bischoff R, van Waarde A; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands., Dierckx RA; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands., Elsinga PH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. Electronic address: p.h.elsinga@umcg.nl.

Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2015 Jan 01; Vol. 23 (1), pp. 192-202. Date of Electronic Publication: 2014 Nov 15.

Quality in Nuclear Medicine

Autor: Andor W.J.M. Glaudemans, Jitze Medema, Annie K. van Zanten, Rudi A.J.O. Dierckx, C.T.B. (Kees) Ahaus

This comprehensive textbook provides a state of the art overview of the means by which quality in patient care is ensured within the field of nuclear medicine. Acknowledged experts in the field cover both management aspects, such as laws, standards,